PLA1A and cancer: Interpreting the effects of NMD factor genetic alterations on NMD efficiency and downstream phenotypes (e.g. cancer patient survival) requires future work on modeling an regulatory network impacting NMD factors, including negative feedback, and its dynamics [52].